Starling Oncology director Brad Hively to step down as Vice Chairman, not seek re-election

Oncology Institute, Inc.

On Sept 1, 2026, Brad Hively notified Starling Oncology he will not stand for re-election at the 2027 annual meeting.
Hively remains a director until the annual meeting but immediately relinquishes Vice Chairman and committee roles.
Company states his decision is not due to any disagreement with operations, policies, or practices.
No replacement named; board composition change effective at 2027 annual meeting.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.